|
|
 |
|
Viewing report
|
|
|
|
Biorepositories: Applications & Ownership - A Global Market Watch, 2009-2015
Axis Research Mind, Nov 2011, Pages: 771
REPORT DESCRIPTION
Global Market Watch:
With a CAGR of 7.9%, global market value for biorepositories market is anticipated to be worth US$23.9 billion by 2015. On a global scale, North America accounts for more than 30% of the market. While US accounts for the highest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in the near future and leads the world. Share of stem cells market in Biorepositories is forecasted to become nearly 30% by 2015, with a massive CAGR of 18.7%. Among the segments, blood Products market is expected to reach US$2.8 billion. Our analysis indicates that human and veterinary uses would worth US$2.6 billion and US$2.8 billion, respectively by 2015. Private Banks are forecasted to be the fastest growing markets over the Public Banks. Asia-Pacific and Europe leads in terms of CAGR among the regions considered. On further classification, Population-Based Banks are the fastest growing segment followed by Academics and Disease-Based Banks respectively.
Report Focus:
The ‘Biorepositories: Applications & Ownership - A Global Market Watch, 2009-2015' reviews the latest trends in biobanking sector with a perceptive to disclose the near-future growth prospects in. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments.
The study offers profitable investment strategies for R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
- Latest Market Trends
- Region-wise Demand Factor
- Key Growth Areas
- Market Sizes
- Key Competitors Edge
- Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the industry. The analysis is based on desk research and interviews with biobank researchers and law/ethics specialists, as well as on data collected through the survey, and discussions with experts.
The report delivers a microscopic view of regional market values.
The major applications & ownership areas discussed in the report are:
BY APPLICATIONS
Stem Cells
Blood Products
Human (Tissue Sections, Brain, Liver, Eyes, Heart, Kidney and Others)
Veterinary
Advanced Applications
- Genomics (DNA, RNA, Protein Extraction, Molecular Derivatives, Cell Cultures, Microarrays, Cytogenetics, etc.) &
- Drug Discovery
- Forensics
Others
BY OWNERSHIP
Private Banks (Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics, Transplantation and Biobank Storage Companies)
- Disease-Based Banks
- Population-Based Banks (Newborns, Adults or Pregnant Women)
- Academics (Medical Institutions, Research and Forensics)
Public Banks
- Disease-Based Banks
- Population-Based Banks (Newborns, Adults or Pregnant Women)
- Academics (Medical Institutions, Research and Forensics)
The report focuses on the current market trends, estimates and forecasts for the period 2009-2015. More than 1100 in biorepositories market and 120 leading market players that project improved market activities in the near future are profiled. The report consists of 291 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.
Countries Covered:
The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Italy, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.
Countries Covered:
The report also covers major industry participants with details of their services, projects and financial status. Below are few among the 120 Biorepositories/Biobanking company profiles in our report:
- Thermo Fisher Scientific
- Sanyo Biomedical
- New Brunswick Scientific
- Labvantage Solutions, Inc.
- Labware, Inc.
- Starlims Corporation
- Genvault Corporation
- Qiagen
- Tecan
- Beckman Coulter
- Atgc Labs
- Dataworks Development, Inc.
- Biostorage Technologies, Inc.
- Pacific Bio-Material Management, Inc.
- Promeddx, Llc
- Seqwright Dna Technology Services
- Steelgate, Inc.
- Wheaton
- Vivakor, Inc
- Novare Biologistics
- Autogen, Inc.
- Caliper Life Sciences, Inc.
- Hamilton Storage
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
